Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Author

Tushar Ingle Shubhangi Lal

View on Semantic Scholar

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#gene editing Open access Sep 2026

Biomimetic Cell Membrane-Coated Nanocarriers for CRISPR-Cas9 Delivery: Recent Advances, Challenges and Future Perspectives

The CRISPR-Cas9 system revolutionized genome editing and is a very promising platform for the treatment of cancers, genetic disorders, and infections. Yet the clinical translation of CRISPR-Cas9 is hampered by some major bottlenecks related to delivery issues, such as fast degradation, poor cellular uptake, and immunog...

Tushar Ingle Shubhangi Lal · 0 citations
#gene editing Open access Sep 2026

Biomimetic Cell Membrane-Coated Nanocarriers for CRISPR-Cas9 Delivery: Recent Advances, Challenges and Future Perspectives

The CRISPR-Cas9 system revolutionized genome editing and is a very promising platform for the treatment of cancers, genetic disorders, and infections. Yet the clinical translation of CRISPR-Cas9 is hampered by some major bottlenecks related to delivery issues, such as fast degradation, poor cellular uptake, and immunog...

Tushar Ingle Shubhangi Lal · 0 citations
#gene editing Open access Sep 2026

Biomimetic Cell Membrane-Coated Nanocarriers for CRISPR-Cas9 Delivery: Recent Advances, Challenges and Future Perspectives

The CRISPR-Cas9 system revolutionized genome editing and is a very promising platform for the treatment of cancers, genetic disorders, and infections. Yet the clinical translation of CRISPR-Cas9 is hampered by some major bottlenecks related to delivery issues, such as fast degradation, poor cellular uptake, and immunog...

Tushar Ingle Shubhangi Lal · 0 citations
#gene editing Open access Sep 2026

Biomimetic Cell Membrane-Coated Nanocarriers for CRISPR-Cas9 Delivery: Recent Advances, Challenges and Future Perspectives

The CRISPR-Cas9 system revolutionized genome editing and is a very promising platform for the treatment of cancers, genetic disorders, and infections. Yet the clinical translation of CRISPR-Cas9 is hampered by some major bottlenecks related to delivery issues, such as fast degradation, poor cellular uptake, and immunog...

Tushar Ingle Shubhangi Lal · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.